HIMS Quantitative Stock Analysis

Validea's guru fundamental report indicates that HIMS & HERS HEALTH INC (HIMS) receives a 75% rating based on their Small-Cap Growth Investor model, which is based on the published strategy of Motley Fool, indicating some interest in the stock. The stock passes key criteria such as profit margin, relative strength, and insider holdings, but fails in areas like cash and cash equivalents, the Fool Ratio (P/E to growth), and sales.

Analysis

Hims & Hers Health Inc. (HIMS) garners "some interest" based on Validea's Small-Cap Growth Investor model, which is derived from the Motley Fool strategy, as indicated by its 75% rating. While this score suggests a degree of fundamental appeal, the model highlights a mixed profile for the large-cap growth stock operating in the Biotechnology & Drugs industry. HIMS successfully passed criteria related to its profit margin, relative price strength, year-over-year sales and EPS growth comparison, insider holdings, cash flow from operations, profit margin consistency, R&D as a percentage of sales, inventory to sales ratio, accounts receivable to sales ratio, long-term debt/equity ratio, and its current price level. However, the company did not meet the model's standards for cash and cash equivalents, "The Fool Ratio" (P/E to growth), average shares outstanding, daily dollar volume, and income tax percentage. Notably, while sales *growth* compared to the prior year period was a pass, a separate "SALES" metric failed, suggesting potential concerns with absolute sales levels or specific model thresholds. The overall neutral sentiment (0.0) for the report, alongside a slightly positive sentiment for HIMS itself (0.4), aligns with this balanced assessment.

Key Decisions for Investors

• Note that HIMS's 75% rating on Validea's Small-Cap Growth model signals "some interest" according to the provided summary, but investors should recognize the mixed nature of the underlying fundamental assessment.
• Focus due diligence on the areas where HIMS failed the model's criteria, particularly its cash position, P/E to growth valuation ("Fool Ratio"), average shares outstanding, and the specific sales metric that was not met, to fully understand potential risks.
• Consider the positive operational indicators, such as profit margin strength and sales/EPS growth, in conjunction with the identified weaknesses and the context of a small-cap model being applied to a large-cap stock.